| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 07/11/1991 | WO1991009592A1 Transdermal system |
| 07/11/1991 | WO1991009590A1 Pharmaceutical preparation of et18-och3 for intravenous administration |
| 07/11/1991 | WO1991007941A3 Methods and compositions for the treatment of hodgkin's disease |
| 07/11/1991 | CA2070814A1 Insulin preparations containing nicotinic acid or nicotinamide |
| 07/11/1991 | CA2033726A1 Topical compositions |
| 07/10/1991 | EP0436428A1 Controlled release device and process for preparing it |
| 07/10/1991 | EP0436373A1 Process for making tablets containing spray-dried naproxen or naproxen sodium |
| 07/10/1991 | EP0436370A1 Controlled release pharmaceutical preparation and method for producing the same |
| 07/10/1991 | EP0436284A1 Stable oral composition of zinc |
| 07/10/1991 | EP0436252A1 Pharmaceutical preparation for oral administration in fluid form |
| 07/10/1991 | EP0436217A2 Anti-inflammatory analgesic patch |
| 07/10/1991 | CN1052788A Controlled release pharmaceutical preparation and method for producing the same |
| 07/09/1991 | US5030722 Odorant-binding protein from rat |
| 07/09/1991 | US5030719 A folic acid-antagonistic folic acid analogue bound to an antibody through an oligopeptide; antitumor and -carcinogenic agents |
| 07/09/1991 | US5030717 Antibodies which catalyze hydrolysis of ester bonds |
| 07/09/1991 | US5030629 Compositions and method comprising heterocyclic compounds containing two heteroatoms as membrane penetration enhancers |
| 07/09/1991 | US5030620 Vinblastine derivatives, and pharmaceutical compositions containing them |
| 07/09/1991 | US5030457 Bioerodible polymers useful for the controlled release of therapeutic agents |
| 07/09/1991 | US5030455 Water-soluble drug; vegetable or synthetic oil; stearic acid, a stearate of glycerin, hydrogenated castor oil, stearyl alcoh ol or a fatty acid sucrose ester |
| 07/09/1991 | US5030452 Dispensing devices powered by lyotropic liquid crystals |
| 07/09/1991 | US5030447 Pharmaceutical compositions having good stability |
| 07/09/1991 | CA1285874C Injectable sustained release formulation |
| 07/06/1991 | CA2033535A1 Method for preparing a dried composition of insulin-like growth factor i |
| 07/04/1991 | DE4000084A1 Intravenoes applizierbare pharmazeutische zubereitung von et18-och(pfeil abwaerts)3(pfeil abwaerts) Intravenously administered pharmaceutical preparation of ET18-och (down arrow) 3 (down arrow) |
| 07/04/1991 | DE3943385A1 Mittel zur transdermalen applikation enthaltend rolipram Means for transdermal administration comprising rolipram |
| 07/04/1991 | CA2029330A1 Stable oral composition of zinc |
| 07/03/1991 | EP0435826A1 Intravenous solutions for epilepsy |
| 07/03/1991 | EP0435684A1 Freeze-dried dosage forms and methods for preparing the same |
| 07/03/1991 | EP0435682A2 The use of inclusion complexes of prostaglandins with cyclodextrins in the treatment of ocular hypertension |
| 07/03/1991 | EP0435450A2 Crystalline sugar alcohol containing uniformly dispersed particulate pharmaceutical compound |
| 07/03/1991 | EP0435436A2 Transdermal flux enhancers in combination with iontophoresis in topical administration of pharmaceuticals |
| 07/03/1991 | EP0435200A2 Estrogen-containing gel preparation |
| 07/03/1991 | EP0398925A4 Growth inhibiting agent and the use thereof |
| 07/03/1991 | CN1052604A Biomembrane adhered medicament prescription and filling technology |
| 07/02/1991 | US5028697 Antitumor agents, cell specific |
| 07/02/1991 | US5028675 Polyamide resin and method for preparation of reagents for immunodiagnostic use |
| 07/02/1991 | US5028667 Yttrium and rare earth compounds catalyzed lactone polymerization |
| 07/02/1991 | US5028664 Drug-release controlling coating material for long acting formulations |
| 07/02/1991 | US5028653 Non-agglomerating elastomeric organopolysiloxane particulates produced by polyaddition crosslinking |
| 07/02/1991 | US5028432 Nonaqueous Matrix of Glyceride and/or Mineral Oil or Paraffin |
| 07/02/1991 | US5028430 Delivery systems for the controlled administration of LHRH analogs |
| 07/02/1991 | CA1285489C Process for the preparation of stabilized isosorbide- 5-mononitrate tablets, being also of sustained release, and formulations thus obtained |
| 07/02/1991 | CA1285488C Pharmaceutical formulation containing indomethacin |
| 07/02/1991 | CA1285485C Nicorandil-containing preparation for injection |
| 07/02/1991 | CA1285483C Sustained release compositions |
| 07/02/1991 | CA1285482C Sustained-release pharmaceutical preparation |
| 07/02/1991 | CA1285478C Stable composition of interleukin-2 |
| 06/29/1991 | CA2031469A1 Use of inclusion complexes of prostaglandins with cyclodextrins in the treatment of ocular hypertension |
| 06/28/1991 | CA2033118A1 Intravenous solutions for status epileptious |
| 06/27/1991 | WO1991009831A1 Prodrug anhydrides of asprin, indomethacin and ibuprofen, their preparation, compositions, and anti-inflammatory method of use |
| 06/27/1991 | WO1991009135A1 Tumor-specific, cell surface-binding monoclonal antibodies |
| 06/27/1991 | WO1991009079A1 Use of supercritical fluids to obtain porous sponges of biodegradable polymers |
| 06/27/1991 | WO1991009058A1 Therapeutic uses of the hypervariable region of monoclonal antibody m195 and constructs thereof |
| 06/27/1991 | WO1991008775A2 Maleic anhydride derivatives used as conjugation agents of anti-tumor agents on desired carriers |
| 06/27/1991 | WO1991008773A1 Tolerogenic immunoglobulin-protein conjugates |
| 06/27/1991 | WO1991008770A1 Method for antibody targeting of diagnostic or therapeutic agents |
| 06/27/1991 | WO1991008765A1 Stabilization of k2p pro |
| 06/27/1991 | WO1991008733A1 Stable cream and lotion bases for lipophilic drug compositions |
| 06/27/1991 | WO1991007437A3 Improved cd-30 antibodies and fragments thereof |
| 06/27/1991 | DE3943541A1 Aluminium magnesium hydroxy fatty acid cpds. |
| 06/27/1991 | DE3942145A1 T-pa-solubilisierung T-pa-solubilization |
| 06/27/1991 | DE3942144A1 Stabilisierung von k1k2p pro Stabilization of K1K2P per |
| 06/27/1991 | DE3942143A1 T-pa pro stabilisierung T-pa per stabilization |
| 06/27/1991 | DE3942142A1 Stabilisierung von glykosyliertem t-pa Stabilization of glycosylated t-pa |
| 06/27/1991 | DE3942141A1 K2p pro-stabilisierung K2p pro-stabilization |
| 06/27/1991 | CA2072360A1 Prodrug anhydride compositions |
| 06/27/1991 | CA2072017A1 Therapeutic uses of the hypervariable region of monoclonal antibody m195 and constructs thereof |
| 06/26/1991 | WO1991009612A1 Tumor cell growth inhibitor |
| 06/26/1991 | EP0434438A2 Hydrolytically degradable hydrophilic gels and the method for preparation thereof |
| 06/26/1991 | EP0434257A2 Chimeric antibody for detection and therapy of infectious and inflammatory lesions |
| 06/26/1991 | EP0433909A2 Formulation |
| 06/26/1991 | EP0433624A1 Pharmaceutical compositions for the topical use containing pyridinol carbamate |
| 06/26/1991 | EP0433452A1 Monoclonal antibody, and assay method, reagent kit, search method and drug missile using said antibody |
| 06/26/1991 | EP0433442A1 Hybrid molecules |
| 06/26/1991 | CA2044621A1 Inhibiting agent against the proliferation of tumour cells |
| 06/25/1991 | US5026827 Amphetamine-protein complex as immunogen for obtaining antibodies specific to methamphetamine |
| 06/25/1991 | US5026825 With aminolevulinic acid |
| 06/25/1991 | US5026821 Sustained release, biodegradable; surgical sutures, prostheses |
| 06/25/1991 | US5026772 Lyophilized pharmaceutical composition of neocarzinostatin derivative |
| 06/25/1991 | US5026556 Buprenorphine in carrier comprises lower alkyl diols or triols and a polar lipid |
| 06/25/1991 | US5026555 Coating anticholesterol particles with lecithin, and mixing with a sweetened partially-set water, gelatin and glycerin mixture and flavors |
| 06/25/1991 | US5026550 Process for the preparation of an antioxydant extract of spices |
| 06/25/1991 | US5026546 Stabilized adjuvant suspension comprising dimethyl dioctadecyl ammonium bromide |
| 06/25/1991 | US5025800 Contraceptive device |
| 06/25/1991 | CA1285227C Long lasting dihydropyridine calcium channel blockers |
| 06/25/1991 | CA1285225C Stabilized immunoglobulin and method of preparation |
| 06/23/1991 | CA2032956A1 Spray drying process for making pharmaceutical powder compositions directly compressible into tablets |
| 06/21/1991 | WO1991009073A1 Uncharged morpholino-based polymers having achiral intersubunit linkages |
| 06/21/1991 | WO1991008767A1 STABILIZATION OF GLYCOSYLIZED t-PA |
| 06/21/1991 | WO1991008766A1 STABILIZATION OF t-PA pro |
| 06/21/1991 | WO1991008764A1 SOLUBILIZATION OF t-PA |
| 06/21/1991 | WO1991008763A1 Stabilization of k1k2p pro |
| 06/21/1991 | CA2046876A1 Stabilisation of glycosated t-pa |
| 06/20/1991 | DE3941061A1 Anionic surfactant - obtd. by sulphating opt. poly:alkoxylated fatty acid sorbitan ester] used in prepn. of surfactant |
| 06/19/1991 | WO1991008678A1 Sustained flavorant release composition, method for making same and chewable structure incorporating same |
| 06/19/1991 | EP0433067A2 A non-specific immunomodulating agent and a process for its production |
| 06/19/1991 | EP0432965A1 Malaria vaccine |
| 06/19/1991 | EP0432956A1 Pharmaceutical lozenges |
| 06/19/1991 | EP0432646A2 Alkoxylated alkyl glucoside ether quaternaries useful in personal care |
| 06/19/1991 | EP0432607A1 Tablets with controlled-rate release of active substances |